- Home
- ELUT vs SOL Comparison
ELUT vs SOL Comparison
Compare ELUT & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELUT
- SOL
- Stock Information
- Founded
- ELUT 2015
- SOL 2005
- Country
- ELUT United States
- SOL United States
- Employees
- ELUT N/A
- SOL N/A
- Industry
- ELUT Medical Specialities
- SOL Semiconductors
- Sector
- ELUT Health Care
- SOL Technology
- Exchange
- ELUT Nasdaq
- SOL Nasdaq
- Market Cap
- ELUT 108.2M
- SOL 104.0M
- IPO Year
- ELUT 2020
- SOL 2008
- Fundamental
- Price
- ELUT $3.20
- SOL $2.04
- Analyst Decision
- ELUT Strong Buy
- SOL Buy
- Analyst Count
- ELUT 2
- SOL 3
- Target Price
- ELUT $10.00
- SOL $3.83
- AVG Volume (30 Days)
- ELUT 46.3K
- SOL 277.9K
- Earning Date
- ELUT 03-06-2025
- SOL 11-14-2024
- Dividend Yield
- ELUT N/A
- SOL N/A
- EPS Growth
- ELUT N/A
- SOL N/A
- EPS
- ELUT N/A
- SOL N/A
- Revenue
- ELUT $24,782,000.00
- SOL $102,489,000.00
- Revenue This Year
- ELUT $4.29
- SOL N/A
- Revenue Next Year
- ELUT $32.21
- SOL $46.42
- P/E Ratio
- ELUT N/A
- SOL N/A
- Revenue Growth
- ELUT N/A
- SOL 25.98
- 52 Week Low
- ELUT $2.28
- SOL $1.41
- 52 Week High
- ELUT $5.24
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- ELUT 40.50
- SOL 51.14
- Support Level
- ELUT $2.86
- SOL $1.86
- Resistance Level
- ELUT $3.33
- SOL $2.17
- Average True Range (ATR)
- ELUT 0.30
- SOL 0.14
- MACD
- ELUT -0.05
- SOL 0.00
- Stochastic Oscillator
- ELUT 24.64
- SOL 40.91
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.